by Pandora Hughes | Feb 20, 2025 | Insights
Clinical Outcome Assessments and LGBTQIA+ Patients A transgender man takes part in a Patient Reported Outcome (PRO) assessment for a new drug. The firsttwo items he reads on the questionnaire are: What was your sex at birth, male or female? Do you menstruate? Why...
by Piper Fromy | Jan 8, 2025 | Insights
Missing data in daily diaries Why do we sometimes collect data from patients daily, rather than weekly or monthly? One of the main reasons is variability in the patient’s condition. Take the example of asthma. Over a week or a month, an asthma sufferer may experience...
by Pandora Hughes | Nov 26, 2024 | Insights
Let’s try a little roleplay. Imagine you are a government official or a family doctor. You’re on a committee considering the licensing of a new drug. It’s the first meeting after lunch, so you’re not at your sharpest. You need the next session to be sharp and focused....
by Piper Fromy | Oct 1, 2024 | Insights
Meet Joanne. Jo has a nasty and persistent foot fungus, so agrees to take part in the trial of a new fungal cream. She is given a questionnaire and asked to rate her fungal problem on a 0-10 scale at the start of the trial, and then again when it’s over. At that...
